In order to investigate S100A4 expression in a chronic in vivo neuroinflammatory condition, we adopted transgenic SOD1-G93A rats (Figure 5A), a model recapitulating the pathological features of ALS [35,36]. Here, S100A4 is linked to amyotrophic lateral sclerosis.